Insider Stock Trading History of Ra Capital Healthcare Fund Ii, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ra Capital Healthcare Fund Ii, L.p. since year 2005. The trader's CIK number is 1392402. At the time of this reporting, Ra Capital Healthcare Fund Ii, L.p. is the 10% Owner of Biospecifics Technologies Corp . (stock ticker symbol BSTC). See this page for all insider trading activities at Biospecifics Technologies Corp .

Note that in the past RA Capital Healthcare Fund II, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ra Capital Healthcare Fund Ii, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-04-24 BSTC Biospecifics Technologies Corp Buy 601 19.00 11,419
2009-04-27 BSTC Biospecifics Technologies Corp Buy 100 19.40 1,939
2009-04-28 BSTC Biospecifics Technologies Corp Buy 15,058 19.47 293,179
2009-04-08 BSTC Biospecifics Technologies Corp Buy 3,301 18.00 59,418
2009-04-09 BSTC Biospecifics Technologies Corp Buy 6,419 19.00 121,961
2009-04-01 BSTC Biospecifics Technologies Corp Buy 1,577 18.50 29,174
2009-04-02 BSTC Biospecifics Technologies Corp Buy 2,432 19.00 46,208
2009-03-10 BSTC Biospecifics Technologies Corp Buy 2,150 18.25 39,237
2009-03-11 BSTC Biospecifics Technologies Corp Buy 2,500 18.80 47,000
2008-11-17 BSTC Biospecifics Technologies Corp Buy 44,000 16.56 728,728
2008-11-18 BSTC Biospecifics Technologies Corp Buy 887 15.00 13,305
2008-10-06 ARDM Aradigm Corp Sale 1,000,000 .35 350,000
2008-10-06 BSTC Biospecifics Technologies Corp Buy 5,900 16.29 96,087
2008-10-07 BSTC Biospecifics Technologies Corp Buy 1,000 14.40 14,400
2008-09-25 BSTC Biospecifics Technologies Corp Buy 14,196 18.25 259,077
2007-03-01 LIPD Lipid Sciences Inc/ Buy 300 1.40 420

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ra Capital Healthcare Fund Ii, L.p. (10% Owner of Biospecifics Technologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.